Collecting movement data from healthy children
Official title: Pediatric Normative Markerless Movement Analysis Data Collection Project
Run by MultiCare Health System Research Institute · NCT06249880 · Data updated 2026-11-12
This study is collecting movement data from healthy children aged 3 to 25 to help understand how kids with leukemia move compared to their peers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Years to 25 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | MultiCare Health System Research Institute Academic / other |
| Locations | 1 site (Puyallup, Washington) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | December 2027 |
| Study ends | December 2028 |
| Registry record updated | March 9, 2026 |
| Trial ID | NCT06249880 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are typically developing children aged 3 to 25 years who can walk independently.
✕Probably not a fit
Patients with neuromuscular disorders or developmental delays will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to gather baseline movement data from a normative population of children aged 3 to 25 years, matching the demographics of pediatric patients expected to be treated at the Mary Bridge Children's Research & Movement Lab. The study will recruit 20 male and 20 female typically developing individuals and will utilize non-invasive motion analysis and force plate data to assess their bipedal gait patterns. The collected data will serve as a reference for understanding movement in children with pediatric acute lymphoblastic leukemia (ALL).
Why it matters
Potential benefit: If successful, this study could provide valuable normative data to improve the assessment and treatment of movement disorders in pediatric ALL patients.
How similar studies have gone: While similar studies have been conducted, this specific approach of collecting normative data for pediatric ALL patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion). * Ambulate independently and without the use of assistive devices or orthoses. * Willing and interested in participating. Exclusion Criteria: * Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues. * Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity. * Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment. * History of premature birth. * Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.
Where it's running
-
Mary Bridge Children's Therapy Unit - Research & Movement Lab
Puyallup, Washington, United States Recruiting
Study contacts
- Principal investigator: Brenna Brandsma — Mary Bridge Chidlren's
- Study coordinator: Brenna Brandsma, PT, DPT, PCS
- Email: brenna.brandsma@multicare.org
- Phone: 253-697-5268
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nature-based program feasibility in preschools near public housing
This feasibility study tests whether a nature-based program in preschools near public housing can be run smoothly and whether families will participate and benefit.
-
Comparing two ultrasound methods for femoral artery access in children
This trial tests whether a modified ultrasound technique helps anesthesia residents place femoral arterial lines faster and with fewer attempts in infants and children having heart surgery.
-
Optimizing therapy components for pediatric PTSD with a multiphase design
This project will try different therapy pieces to see which combinations help children and teens (ages 8–17) with PTSD feel better.
-
Registry of long-term outcomes for children after cardiac arrest
This study is looking at the long-term health and recovery of children in the Netherlands who have had a cardiac arrest to see how well they do after treatment.
-
Evaluating sedation effectiveness with dexmedetomidine in children undergoing brain MRI
This study is testing if a nasal spray of dexmedetomidine can safely and effectively help children aged 12 months to 18 years relax during a brain MRI.
-
Pediatric eCART: an electronic tool to spot children at high risk of critical illness
This project will test whether implementing pediatric eCART, an EHR-based risk alert system, helps identify hospitalized children at high risk of life-threatening deterioration and is acceptable to pediatric nurses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.